{"id":"W4365517174","doi":"10.1016/s1473-3099(23)00047-6","title":"Redefining Clostridioides difficile infection antibiotic response and clinical outcomes","year":2023,"lang":"en","type":"review","venue":"The Lancet Infectious Diseases","topic":"Clostridium difficile and Clostridium perfringens research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Calgary","funders":"Universitätsklinikum Heidelberg; Falk Foundation; Universitätsklinikum Köln; Astellas Pharma; Nabriva Therapeutics; Seres Therapeutics; European Tissue Symposium; Idorsia Pharmaceuticals; European Federation of Pharmaceutical Industries and Associations; GlaxoSmithKline; Pfizer; Gilead Sciences; Da Volterra; U.S. Department of Veterans Affairs","keywords":"Clostridioides; Medicine; Antibiotics; Clinical endpoint; Internal medicine; Day treatment; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00162813,0.0007473692,0.003068607,0.001534908,0.0001269267,0.000904258,0.0007056749,0.001213116,0.004558686],"category_scores_gemma":[0.004428174,0.0002906196,0.002010799,0.00165318,0.0003413063,0.0006469973,0.0005735163,0.001745177,0.0004107454],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007743912,"about_ca_system_score_gemma":0.001488282,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001792852,"about_ca_topic_score_gemma":0.004345003,"domain_scores_codex":[0.9993117,0.0002420201,0.0001599491,0.00007707219,0.0001438976,0.00006528941],"domain_scores_gemma":[0.9975271,0.001747761,0.0004826065,0.00002592151,0.0001503197,0.00006642256],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001351808,0.00009906081,0.0009418332,0.253536,0.005182482,0.000142697,0.00007556473,0.0002712932,0.0005380547,0.001209113,0.01901099,0.7176412],"study_design_scores_gemma":[0.004197825,0.002778164,0.02612617,0.3787183,0.0613119,0.001579244,0.0003841208,0.0004536533,0.001056729,0.003531902,0.5197297,0.0001323066],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001348738,0.9995127,0.00001076351,0.0001328723,0.00008924132,0.000002820684,0.00001176671,0.000001225555,0.000103776],"genre_scores_gemma":[0.003268698,0.9959824,0.00006331814,0.0003988156,0.000178607,0.0000102083,0.00002222076,8.764492e-7,0.00007494502],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004558686,"threshold_uncertainty_score":0.01525033,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1410203808154763,"score_gpt":0.4354129077907551,"score_spread":0.2943925269752788,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}